HR 6174
114th Congress
House
Health
Drug therapy
Health care costs and insurance
Inflation and prices
Prescription drugs
Closing Loopholes for Orphan Drugs Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 27, 2016
Referred to the House Committee on Energy and Commerce.
Sep 27, 2016
Introduced in House
Plain-English summary
Closing Loopholes for Orphan Drugs Act
This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1
Cosponsors
1